Zhang Wen-Xiong, Nishiura Masayoshi, Hou Zhaomin
Organometallic Chemistry Laboratory, RIKEN (The Institute of Physical and Chemical Research), Hirosawa 2-1, Wako, Saitama 351-0198, Japan.
Chemistry. 2007;13(14):4037-51. doi: 10.1002/chem.200601383.
Reaction of [Ln(CH(2)SiMe(3))(3)(thf)(2)] (Ln=Y, Yb, and Lu) with one equivalent of Me(2)Si(C(5)Me(4)H)NHR' (R'=Ph, 2,4,6-Me(3)C(6)H(2), tBu) affords straightforwardly the corresponding half-sandwich rare-earth metal alkyl complexes [{Me(2)Si(C(5)Me(4))(NR')}Ln(CH(2)SiMe(3))(thf)(n)] (1: Ln = Y, R' = Ph, n=2; 2: Ln = Y, R' = C(6)H(2)Me(3)-2,4,6, n=1; 3: Ln = Y, R' = tBu, n=1; 4: Ln = Yb, R' = Ph, n=2; 5: Ln = Lu, R' = Ph, n=2) in high yields. These complexes, especially the yttrium complexes 1-3, serve as excellent catalyst precursors for the catalytic addition of various primary and secondary amines to carbodiimides, efficiently yielding a series of guanidine derivatives with a wide range of substituents on the nitrogen atoms. Functional groups such as C[triple chemical bond]N, C[triple chemical bond]CH, and aromatic C--X (X: F, Cl, Br, I) bonds can survive the catalytic reaction conditions. A primary amino group can be distinguished from a secondary one by the catalyst system, and therefore, the reaction of 1,2,3,4-tetrahydro-5-aminoisoquinoline with iPrN==C==NiPr can be achieved stepwise first at the primary amino group to selectively give the monoguanidine 38, and then at the cyclic secondary amino unit to give the biguanidine 39. Some key reaction intermediates or true catalyst species, such as the amido complexes [{Me(2)Si(C(5)Me(4))(NPh)}Y(NEt(2))(thf)(2)] (40) and [{Me(2)Si(C(5)Me(4))(NPh)}Y(NHC(6)H(4)Br-4)(thf)(2)] (42), and the guanidinate complexes [{Me(2)Si(C(5)Me(4))(NPh)}Y{iPrNC(NEt(2))(NiPr)}(thf)] (41) and [{Me(2)Si(C(5)Me(4))(NPh)}Y{iPrN}C(NC(6)H(4)Br-4)(NHiPr)}(thf)] (44) have been isolated and structurally characterized. Reactivity studies on these complexes suggest that the present catalytic formation of a guanidine compound proceeds mechanistically through nucleophilic addition of an amido species, formed by acid-base reaction between a rare-earth metal alkyl bond and an amine N--H bond, to a carbodiimide, followed by amine protonolysis of the resultant guanidinate species.
[Ln(CH(2)SiMe(3))(3)(thf)(2)](Ln = Y、Yb和Lu)与一当量的Me(2)Si(C(5)Me(4)H)NHR'(R' = Ph、2,4,6-Me(3)C(6)H(2)、tBu)直接反应,高产率地得到相应的半夹心稀土金属烷基配合物[{Me(2)Si(C(5)Me(4))(NR')}Ln(CH(2)SiMe(3))(thf)(n)](1:Ln = Y,R' = Ph,n = 2;2:Ln = Y,R' = C(6)H(2)Me(3)-2,4,6,n = 1;3:Ln = Y,R' = tBu,n = 1;4:Ln = Yb,R' = Ph,n = 2;5:Ln = Lu,R' = Ph,n = 2)。这些配合物,尤其是钇配合物1 - 3,是将各种伯胺和仲胺催化加成到碳二亚胺的优异催化剂前体,能高效地生成一系列氮原子上带有各种取代基的胍衍生物。诸如C≡N、C≡CH和芳族C - X(X:F、Cl、Br、I)键等官能团能在催化反应条件下保持稳定。伯氨基和仲氨基可通过催化剂体系加以区分,因此,1,2,3,4 - 四氢 - 5 - 氨基异喹啉与iPrN==C==NiPr的反应可先在伯氨基上逐步进行,选择性地得到单胍38,然后在环状仲氨基单元上反应得到双胍39。一些关键的反应中间体或真正的催化剂物种,如酰胺基配合物[{Me(2)Si(C(5)Me(4))(NPh)}Y(NEt(2))(thf)(2)](40)和[{Me(2)Si(C(5)Me(4))(NPh)}Y(NHC(6)H(4)Br - 4)(thf)(2)](42),以及胍基配合物[{Me(2)Si(C(5)Me(4))(NPh)}Y{iPrNC(NEt(2))(NiPr)}(thf)](41)和[{Me(2)Si(C(5)Me(4))(NPh)}Y{iPrN}C(NC(6)H(4)Br - 4)(NHiPr)}(thf)](44)已被分离并进行了结构表征。对这些配合物的反应活性研究表明,目前胍化合物的催化形成机理是通过稀土金属烷基键与胺N - H键之间的酸碱反应形成的酰胺物种对碳二亚胺进行亲核加成,随后所得胍基物种发生胺质子解。